Background and Aims: Intoxications by aliphatic halogenated hydrocarbons (AHH), used as effective solvents, are rare and may cause life-threatening liver injury. Patients with acute intoxications by AHH received an innovative treatment. Methods: Analyzed were data of 60 patients intoxicated by AHH, such as dichloromethane (n = 3), chloroform (n = 2), carbon tetrachloride (n = 12), 1,2-dichloroethane (n = 18), 1,1,2-trichloroethane (n = 2), trichloroethylene (n = 2), tetrachloroethylene (n = 13) or mixed AHH chemicals (n = 8), who received a new treatment consisting of CO 2 -induced hyperventilation to accelerate toxin removal via the lungs. Results: Added to the inspiration air at a flow rate of 2-3 Liter min −1 , CO 2 increased the respiratory volume up to 25-30 Liter min −1 , ensuring forced AHH exhalation. This CO 2 -induced hyperventilation therapy was commonly well tolerated by the 60 patients and lasted for 106.0±10.5 hours. In most cases, initially increased liver test results of aminotransferases normalized quickly under the therapy, and liver histology obtained at completion of the therapy revealed, in the majority of patients, normal findings or fatty changes, and rarely severe single cell necrosis but no confluent liver cell necrosis. Despite therapy, clinical outcome was unfavorable for 4/60 patients (6.7%) of the study cohort, due to single or combined risk factors. These included late initiation of the CO 2 -induced hyperventilation therapy, intentional intoxication, uptake of high amounts of AHH, concomitant ingestion of overdosed drugs, consumption of high amounts of alcohol, and history of alcohol abuse. Conclusions: For intoxications by AHH, effective therapy approaches including forced hyperventilation to increase toxin removal via the lungs are available and require prompt initiation. Citation of this article: Teschke R. Aliphatic halogenated hydrocarbons: Report and analysis of liver injury in 60 patients.
Introduction
Applied in animal models, a variety of potentially hepatotoxic chemicals are known, such as ethionine, gallactosamine, nitrosamines, phosphorous and thioacetamide, and are considered as appropriate examples for experimental liver injury studies. 1 However, results obtained with these substrates are rarely transferrable from animal liver injury to human liver injury cases or to general human liver diseases of alternative etiologies, such as those caused by alcohol, drugs, herbs, obesity and hepatitis B or C. Other chemicals like those of the aliphatic halogenated hydrocarbons (AHH) group with compounds presenting a broad spectrum of different structures are much more specific in producing liver injury [1] [2] [3] and have the advantage of causing liver injury in both animals [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and humans. [14] [15] [16] Mimicking human disease, this allows for the transfer of experimental results to patients with intoxications by AHH. [14] [15] [16] Consequently, such data transfer helps elucidate pathogenetic steps of liver injury hits and develop new therapy strategies. 15, 16 This will assist clinicians caring for patients with liver injury caused by AHH.
This article describes and analyzes the clinical experience among 60 patients with acute intoxications by seven different AHH, including dichloromethane, chloroform, carbon tetrachloride (CCl 4 ), 1,2-dichloroethane, 1,1,2-trichloroethane, trichloroethylene, and tetrachloroethylene. The focus is on new therapy approaches based on results of experimental and clinical studies, which include increased pulmonary removal of the toxin via the innovative CO 2 -induced hyperventilation therapy and decreased production of toxic intermediates generated from the parent chemical.
Methods

Patients
The study cohort consisted of 60 patients with acute intoxications by seven different AHH, who were treated at the Intensive Care Unit affiliated to the Medical Departments of the Heinrich Heine University Hospital in Düsseldorf, Germany. The diagnosis of AHH intoxication was verified in the expiration air by the Draeger-tube ® system 15, 16 or in the blood by
All patients received the therapy as systematically described in earlier reports. 15, 16 
Treatment modalities
Patients intoxicated by AHH through ingestion or inhalation were treated as outlined in detail in Table 1 .
Hyperventilation for increasing AHH elimination via lungs
To get the body rid of the toxin, an increased pulmonary removal is recommended, best achieved by artificial hyperventilation through CO 2 at a flow rate of 2-3 Liter min −1 applied via a conventional nose tube or a conventional sealed nasal oxygen mask, with general details and potentially improved mask devices published recently. 15, 16 This is certainly the preferred and most innovative approach in adult and adolescent patients with sustained spontaneous respiration. However, in patients with insufficient spontaneous breathing and especially in children, who are quickly exhausted if treated with the nasal tube or the mask device, endotracheal intubation is recommended, whereby CO 2 at a flow rate of 2-3 Liter min −1 is added to the inspiration air. 15, 16 Independent from the mode of CO 2 treatment, a respiratory volume of 25-30 Liter min −1 should be achieved, to be verified by regular measurement of the minute respiratory volume in order to achieve early recognition of problems requiring technical adjustments of the CO 2 flow or eventually stopping the therapy.
Chronic obstructive pulmonary disease is commonly a contraindication for a CO 2 -induced therapy or requires a case by case decision whether a cautious therapy can be initiated under strict surveillance. All patients with acute AHH intoxication requiring therapy should be treated in a special setting, such as an intensive care unit that provides experienced pulmonologists and gastroenterologists, as this is a critical therapy in need of a careful 24-hour surveillance of the patient with a regular medical and technical control management.
Cimetidine for inhibiting microsomal AHH metabolism
Liver injury of AHH, including CCl 4 , depends on its microsomal conversion to toxic intermediates through cytochrome P450 (CYP), especially its isoenzyme CYP 2E1. 3, 16 Reducing the microsomal metabolism of AHH can be another therapy strategy, using chemicals or drugs that compete with AHH at the site of CYP. For instance, such a competing drug is cimetidine, which reduced liver injury and lethality rate in the CCl 4 animal model. 13 Based on these experimental results, cimetidine has been introduced early as an essential part in the therapy management of humans intoxicated by AHH (Table 1) . 15, 16 Cimetidine may also be protective in kidneys which exhibit CYP450 2E1, 16, 17 possibly responsible for renal injury associated with liver injury found in some patients intoxicated by AHH. 15, 16, 18 Glucose for down-regulating microsomal functions High-dose glucose, daily 400 g for a few days, is advised as part of the infusion program in patients intoxicated by AHH (Table 1) , 15, 16 in analogy to the high amounts of glucose given to patients with acute intermittent porphyria. 19 This allows down-regulation of the hepatic d-aminolevulinic acid (ALA) synthase activity, helping to reduce ALA synthesis, 20, 21 and impairs the synthesis of heme that is essential for the hemoprotein CYP. 21 This ALA-dependent pathway has been established by studies through incorporation of radioactive ALA into microsomal CYP. 22 
Results
Intoxicating AHH chemicals and affected patients
The overall study cohort consisted of 60 patients, with 52 patients intoxicated by single AHH and 8 patients with intoxication by AHH chemical mixtures classified as mixed AHH chemical intoxications. The 52 patients had been intoxicated by seven single AHH, with preference of 1,2-dichloroethane intoxicating 18 patients, trichloroethylene affecting 13 patients, and CCl 4 injuring 12 patients (Supplemental Table 1 ). The remaining AHH injured 2-3 patients.
Demographic data of the cohort and mode of intoxication
The 60 patients were 41.3±3.9 years-old, with a first peak occurring between 15 and 24 years of age and a second peak between 35 and 54 years of age (Fig. 1A) . Patients with an accidental intoxication were significantly older compared to those with an intentional intoxication (49.8±6.5 vs. 31.6±2.8 years; p<0.005). Age was also variable among the different subgroups of intoxicating AHH chemicals (Supplemental Table 1 ). Intoxications by AHH occurred mostly by ingestion and rarely by inhalation. There were slightly more intoxications with an unintentional than an intentional background, and male patients constituted the majority among the study cohort (Fig. 1B) . More specifically, in the cohort, the ratio of males:females was 2.5:1, based on 43 male patients and 17 female patients. Gender differences are also evident for the criteria of ingestion, inhalation, intentional use, and unintentional uptake (Fig. 1C) . During the day, a high peak of intoxication was at 4:00 p.m., and another but lower peak occurred at 11:00 a.m. (Fig. 1D) . For the week days, most of the intoxications occurred on Tuesday, followed by Friday and Saturday (Fig. 1E ). For time of year, intoxications by AHH occurred most frequently in January, followed by June (Fig. 1F) .
Hyperventilation details
Duration of the hyperventilation therapy was 106.0±10.5 hours among the 60 patients. Data were variable among the single chemical intoxicants and the mixed chemical intoxication subgroup and were also stratified according to whether the intoxication had an intentional or an Abbreviation: AHH, aliphatic halogenated hydrocarbons.
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Liver injury
Upon assessing maximum serum activities of alanine transaminase (AST) and alanine transaminase (ALT) in the study cohort of 60 patients during the hyperventilation treatment, variable results were evident among the AHH ( Fig. 2A and  2B ). In patients intoxicated by CCl 4 , extremely high values were found for AST ( Fig. 2A) and ALT (Fig. 2B ).
In the initial phase of the clinical study, patients underwent liver biopsy or laparoscopy to obtain liver specimens. Among the 17 patients studied for liver changes, the liver of 12 patients appeared normal upon staining by hematoxylin & eosin or showed steatosis (Supplemental Table 3 ). However, 2 of the remaining patients tolerated only short-term hyperventilation therapy and their liver disease had to be classified as severe hepatocellular, whereas in 3 other patients, severe liver cell necrosis was found, triggered likely by preexisting alcohol abuse or caused by ingestion of high amounts of AHH. More importantly, among patients with normal or near normal liver histology by light microscopy, electron microscopy data were available for a few patients, showing hepatocellular changes such as mitochondrial injury. As expected, liver injurious effects, though at a low level, were still evident at the time of discontinuation of the therapeutic hyperventilation, but this is not of clinical relevance and does not require a prolongation of the hyperventilation therapy. In the further course after discharge, complete restoration of the previous liver injury is expected but it may take some time, until the AHH stored in various organs, including the fat tissue, has left the body. Considering these aspects, all patients were advised at discharge to abstain from alcohol use for at least 3 months.
Renal injury
Maximum serum creatinine values are illustrated for all AAH during the hyperventilation therapy, with the highest values found in patients intoxicated by CCl 4 (Fig. 2C) . Therefore, all patients intoxicated by AHH require continuous analysis of serum creatinine values and early decision to introduce forced diuresis (Table 1) , to help prevent or ameliorate renal insufficiency. Despite these preventive measures, a few patients of the study cohort required dialysis.
Clinical course and outcome
A brief overview of the 52 patients with intoxications by a single AHH is presented in Table 2 and of the 8 patients with mixed chemical intoxications by AHH in Table 3 .
Clinical course was favorable among 56/60 patients, but outcome was fatal in 4/60 patients, corresponding to a lethality rate of 6.7%. In those patients with a fatal outcome, the ratio of males:females was 3:1. All patients with a fatal outcome had used AHH intentionally (cases 13, 37 and 47 in Table 2 ; case 7 in Table 3 ). In more detail, a 22 year-old male patient (case 7 in Table 3 ) ingested 60 mL 1,2-dichloroethane plus 90 mL1,1,2-trichloroethane and was treated by CO 2 -induced hyperventilation, initiated 5 hours after intoxication; death occurred 25 hours after the intoxication (case 7 in Table 3 ). The second patient (case 37 Intentional ingestion of CCl 4 accessed from a dry cleaning business where her mother was employed. She was fully oriented. Liver histology at termination of the hyperventilation therapy showed no overt liver cell necrosis but severe microvesicular fatty liver in 80-90% of the liver cells. By electron microscopy, cristae of mitochondria were reduced and disorganized. Within the mitochondria, crystalline inclusion bodies were found. At discharge all laboratory values were in the normal range. Following intentional ingestion of CCl 4 , the somnolent patient received short-term endotracheal intubation for initiating CO 2 -induced hyperventilation during transport via plane. Maximum values for serum activities of AST and ALT were observed on day 4 after ingestion, associated with an increase of serum creatinine. Liver histology on day 14 after ingestion revealed moderate centrilobular microvesicular fatty liver with low liver cell necrosis. Electron microscopy showed a striking proliferation and pronounced dilatation of the smooth endoplasmic reticulum of the hepatocytes. These dilated cisterns contained small membrane vortexes, similar to myelin. In the cytoplasm, vacuoles predominated. Mitochondria were enlarged and showed degeneration and vacuoles. Microvilli presented with injurious irregularities. Abnormal laboratory results returned to normal values rapidly. 4 and consumed beer (;2.5 Liter) and hard liquor (;0.5 Liter). At admission, his blood ethanol was 2.5-3.0. On day 3 after ingestion, a peak activity was observed for AST and AST, with subsequent decline. Serum total bilirubin and creatinine increased steadily. Endotracheal intubation, dialysis, and two reanimations were required. Complications included acute liver failure, pneumonia, and respiratory insufficiency, leading to a fatal outcome.
(continued ) Table 2 ), a 19 year-old man, died 122 hours after ingestion of 1,1,2-trichloroethane in unknown amounts and of temazepam after transfer in moribund conditions for hyperventilation therapy at 111 hours following ingestion. The third patient (case 47 in Table 2 ) was a 20 year-old woman, who had ingested 100 mL trichloroethylene combined with diclofenac, hydrochlorothiazide, and acetyl salicylic acid. The fourth patient (case 13 in Table 2 ) was a 36 year-old male, who had ingested 50 mL CCl 4 , 0.5 Liter hard liquor, and 1-2 Liter beer, resulting in a blood alcohol level of 3& at admission. Various factors may influence the clinical outcome. These include early start and extent of primary toxin elimination through vomiting, gastrointestinal lavage, and CO 2 -induced hyperventilation, apart from effectivity of the intravenously applied cimetidine and glucose in high amounts. Risk factors are also intentional intoxication, uptake of high amounts of AHH, concomitant ingestion of overdosed drugs with high amounts of alcohol, and a history of alcohol abuse.
Individual cases with liver injury caused by specific AHH
Dichloromethane: Intoxications caused only small changes in laboratory values ( Fig. 2A-2C ). The clinical course was without peculiarities (cases 1-3 in Table 2 ). Chloroform: Intoxications occurred in 2 patients (cases 4 and 5 in Table 2 ), leading to variably increased serum activities of AST and ALT ( Fig. 2A and 2B ) but leaving serum creatinine levels unchanged (Fig. 2C) . As an example, the data for 1 of the cases are presented with all details in Fig. 3A . CCl 4 : For some of the 12 patients experiencing intoxications (cases 6-17 in Table 2 ), high values were found for serum activities of AST ( Fig. 2A) and ALT (Fig. 2B) . Although treatment included forced diuresis, patients were also at risk for renal injury, as evidenced by increased serum levels of creatinine (Fig. 2C) . The data for 1 patient (case 6 in Table 2 ) with an uneventful outcome are illustrated in Fig. 3B . 1,2-Dichloroethane: For the overall 18 patients (cases 18-35 in Table 2 ), laboratory values of serum AST, ALT and creatinine were only moderately elevated or remained in the normal range ( Fig. 2A-2C) . The data for a typical case are presented with all details in Fig. 4A . 1,1,2-Trichloroethane: Considered were 2 patients (cases 36 and 37 in Table 2 ). Only 1 of the patients presented with high laboratory values ( Fig. 2A-2C) . Trichloroethylene: For all 13 patients (cases 38-50 in Table 2 ), laboratory values were mostly unchanged or rarely moderately increased ( Fig. 2A-2C ). The data for 1 of these patients are given with all details in Fig. 4B . Tetrachloroethylene: Among the 2 patients (cases 51 and 52 in Table 2 ), serum activities of aminotransferases were either unchanged or slightly increased ( Fig. 2A and 2B) , whereas serum creatinine presented with moderately increased levels despite forced diuresis (Fig. 2C) . Mixed AHH chemical intoxications: Overall, 8 patients experienced intoxications with variable combinations of AHH chemicals (cases 1-8 in Table 3 ). Serum activities remained unchanged or were slightly increased for AST ( Fig. 2A) and Intentional ingestion, together with diclofenac (1.0 g), hydrochlorothiazide (1.5 g), and acetyl salicylic acid (5.6 g). Narcosis, endotracheal intubation. After transfer, start with hyperventilation by means of a respirator and adding CO 2 to the inspiration mixture, which reduced serum trichloroethylene levels from >1 mg/mL down to 1 mg/mL. Serum activities of AST and ALT remained normal. The clinical course was fatal due to respiratory insufficiency and complications, ascertained by autopsy: Purulent trachea-bronchitis, pneumonia, and congestion of the liver.
Male, 28 years
Trichloroethylene; Ingestion (>500 mL)
Intentional ingestion. Spontaneous and later self-induced vomiting. Narcosis. Serum activities of AST and ALT remained in the normal range. Case data are presented in condensed form. For listed patients with intoxications by CCl 4 , many additional data of interest are available, though not included in this table; the data had been reported previously in a recent publication. 16 For all patients with intoxication by ingestion of AHH, treatment was commonly initiated in the local hospital by gastrointestinal lavage, sometimes already. Intoxicated patients by ingestion or inhalation all received the CO 2 -induced hyperventilation therapy, whereby CO 2 was provided via nasal tube and rarely via an oxygen mask. A few patients required endotracheal intubation and received CO2 together with the inspiration air. Treatment was provided as outlined (Table 1) .
Abbreviations: AFLD, alcoholic fatty liver disease: ALT, alanine transaminase; AST, aspartate transaminase; CCl 4 , carbon tetrachloride; COPD, chronic obstructive pulmonary disease.
Journal of Clinical and Translational Hepatology 2018 vol. 6 | 350-361 357 Only patients intoxicated by ingestion received a gastrointestinal lavage, all patients were treated with the CO2-induced hyperventilation according to described details (Table 1) .
Abbreviation: CCl4, carbon tetrachloride. Table 2 ) was a house painter and had stored chloroform in a beer bottle, from which he erroneously ingested 50 mL chloroform. Prior to intoxication, he had drank 1.5 L beer contained in other beer bottles. Narcosis requiring endotracheal intubation for gastrointestinal lavage and short-term artificial ventilation. The CO2-induced hyperventilation was started 6 hours after ingestion, whereby a respiratory volume between 24 and 34 Liter min-1 was achieved as shown at the top of the figure. Via a nasal tube, CO 2 was provided at a flow rate of 3 to 6 Liter min
. Blood showed pH that was between 7.36 and 7.46, PO2 between 83 and 110 mmHg, PCO2 between 35 and 55, and HCO3 between 21 and 31, and respiratory frequency between 15 and 30 min . The therapy using hyperventilation was well tolerated by the cooperative patient and had to be extended for 19 days because serum activities of AST and ALT declined slowly. Serum activities of liver enzymes showed two peaks. On day 2, AST was 850 U/L and ALT was 1330 U/L on day 3. Both enzymes declined and had a second peak on day 15, with AST of 300 U/L and ALT of 890 U/L. Total bilirubin was in a range between 0.8 and 2.1 mg/dL. Hemoglobin was between 11.8 and 15.5, erythrocytes between 3800 and 4800, leucocytes between 5.100 and 11500. Serum creatinine remained in the normal range, considering that forced diuresis was provided for prophylactic reasons. Liver biopsy obtained at laparoscopy on day 24 revealed a striking proliferation of stellate cells, no fatty changes of the hepatocytes, and no necrosis by light microscopy. (B) Serum activities of AST, ALT, and GDH after intoxication by ingested CCl 4 . The patient (case 6 in Table 2 ) intentionally swallowed 30 mL CCl 4 , vomited twice, and received a gastrointestinal lavage. CO2-induced hyperventilation was started 9 hours after intoxication and continued for 11 days. CO2 was applied via a nasal tube at a flow rate of 2-4 Liter min Other laboratory test were in the normal range, except leucocytes (at 14400). Liver biopsy on day 13 showed no abnormalities. The patient was discharged on day 15.
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; CCl 4 , carbon tetrachloride; GDH, glutamate dehydrogenase.
ALT (Fig. 2B) , while serum levels of creatinine were virtually normal except for in 1 patient (Fig. 2C) .
Discussion
This report provides highlights and a comprehensive overview of an innovative therapy approach applied in 60 patients with acute intoxications by AHH, focusing on the CO 2 -induced hyperventilation ( Table 1 ). The basic idea to treat patients intoxicated by AHH using forced ventilation originated from preliminary results of a single case published by PebayPeyroula and Nicaise. 23 Subsequently, this new form of therapy was clinically introduced and refined at the Heinrich Heine University hospital of Düsseldorf in Germany, first in children 18, 24 and later in adults, with the aim to present practical and specific recommendations (Table 1) . 15, 16 Several experimental and clinical studies have since provided additional data in support of the CO 2 -induced hyperventilation therapy. For instance, intoxicating AHH, such as CCl 4 , taken up by animals are mostly eliminated (99%) through the lungs, 25 while up to 44% of the AHH taken up by humans are eliminated via the lungs at a rate of up to 44% within the first hour. 26 Furthermore, addition of CO 2 to the inspiration air of patients with AHH intoxication increased the minute respiration volume via an increased respiration frequency, and pulmonary exhalation of CCl 4 was in parallel with the minute respiratory expiration volume. 16 Reduced respiration due to pneumonia caused increased blood levels of CCl 4 in intoxicated patients. 14, 16 Conditions similar to intermittent interruption of the hyperventilation therapy that also led to temporarily increased blood levels of CCl 4 until reintroduction of the CO 2 -induced hyperventilation therapy again caused a decline of blood levels. 16 The beneficial effect of hyperventilation had been ascertained in an experimental model of liver injury by CCl 4 . 11, 12, 14 For instance, experimental CO 2 -induced hyperventilation applied in CCl 4 intoxication attenuated the extent of liver injury, 11 significantly reduced the LD 50 , 11, 16, 27 and diminished CCl 4 levels in blood, liver and fat tissue. 12, 16 The combination of these facts led to the refinement of the hyperventilation therapy 15, 16 that was applied in the 60 patients of this study (Supplemental Tables 1 and 2 ).
In the clinical setting of the studied 60 patients with AHH intoxication, the individual contribution of hyperventilation on reducing liver injury is difficult to assess, due to existing confounders. For instance, the study cohort was not homogenous with respect to variability of AHH as intoxication chemicals; most patients experienced vomiting which contributed to toxin elimination, and all patients with intoxication by ingestion received a gastrointestinal lavage for primary toxin elimination. Finally, patients intoxicated by ingestion or inhalation received a therapy that included high glucose infusion and intravenously given cimetidine. Considering the liver test results for AST and ALT, in a few patients the serum activities of AST and ALT remained in the normal range during the observation period under therapy. Other patients had high serum activities of AST ( Fig. 2A) and ALT (Fig. 2B) , suggesting that the therapy approaches taken together will not be able to prevent liver injury completely. Nevertheless, clinical experience strongly suggests that therapy for intoxicated patients should be initiated as soon as possible, starting with gastrointestinal lavage in the intubated patient with intoxication by ingestion as the first measure in the local hospital that first takes care of the patient.
Intoxications by AHH and related liver toxicity is a worldwide issue, with partially high lethality rates as shown by abundant publications; as examples, a few of these are selectively referenced. The low lethality rate of 6.7% in the present study is encouraging but cannot be fully appreciated due to the lack of an appropriate control group of patients who did not receive the therapy outlined in this study (Table 1) . Despite these shortcomings, it is hoped that more patients with acute AHH intoxications will receive this therapy and experience their Table 2 ) intentionally ingested 80 mL dichloroethane. After vomiting and gastrointestinal lavage 4 hours after ingestion, the usual CO2-induced hyperventilation was started using for CO2 application by the nasal tube approach to achieve a respiratory volume between 20 and 33 Liter min Table 2 ) intentionally ingested 70 mL trichloroethylene together with Stroh rum. Known alcohol abuse. Vomiting, narcosis, endotracheal intubation prior to gastrointestinal lavage. Suspected shock in lungs, artificial ventilation combined with CO2-induced hyperventilation for 8 days, whereby CO2 was added to the inspiration air. Already at admission, the serum activities of AST (140 U/L) and of ALT (110 U/L) were slightly increased, followed by rapid normalization. At laparoscopy 1 month after intoxication, suspicion of fatty liver, confirmed by histology showing severe macrovesicular fatty liver without necrosis or infiltration considered compatible with alcoholic fatty liver but not with alcoholic steatohepatitis or alcoholic hepatitis. Shortly after admission, the patient experienced withdrawal symptoms requiring specific drug treatment. The initially increased AST and ALT activities were likely due to the preexisting alcohol abuse associated with alcoholic fatty liver, considering that AST values were higher than ALT values, providing a ratio of AST/ ALT of >1.0 that is highly suggestive for alcohol as cause. Such a ratio was not observed in any other patients intoxicated by AHH, who all had higher values of ALT than of AST.
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; GDH, glutamate dehydrogenase.
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Conclusions
With the establishment of modern, active therapeutic approaches, including CO 2 -induced hyperventilation, the prognosis is now substantially better for patients acutely intoxicated by AHH, provided treatment is initiated without delay and replacing a wait-and-see approach conflicted by poor prognosis. In the near future, progress can be expected after successful search for additional drugs or compounds that provide inhibition of AHH metabolism, which may be better than the cimetidine that is used as the preferred drug presently. Studying such inhibition at the level of CYP 2E1 is facilitated using experimental CCl 4 models, because their result can easily be transferred to patients intoxicated by CCl 4 or other AHH. Inhibitor candidates may come from drugs already on the market or from Herbal & Traditional Chinese Medicine.
